Switching from sildenafil to riociguat for the treatment of PAH and inoperable CTEPH: Real-life experiences

Riociguat is a novel soluble guanylate cyclase stimulator that is approved for the treatment of patients with pulmonary arterial hypertension (PAH) and patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent/recurrent CTEPH after pulmonary endarterectomy (PEA). A...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Respir Med Case Rep
Main Authors: Andersen, Asger, Korsholm, Kasper, Mellemkjær, Søren, Nielsen-Kudsk, Jens Erik
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2017
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5476463/
https://ncbi.nlm.nih.gov/pubmed/28652963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.06.005
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker